These protective effects of omentin in both obesity and cardiovascular disease seem to be based on disease-specific effects, for example, an insulin sensitizing effect in obesity [36] and modulation of NO synthase function in the coronary endothelium [37]. This evidence concerns the gene INS and cardiovascular disorder.